Open | 0.96 |
Previous Close | 0.99 |
Day Range | 0.93 - 0.99 |
52-Week Range | 0.89 - 2.98 |
All-Time High | 7.25 |
Avg. Volume (50-day) | 57,967.52 |
EPS (TTM) | -0.3698 |
Next Earnings Date | 2024-07-01 |
Last Earnings Date | 2024-02-14 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -2.5100 |
PEG Ratio | - |
Price to Book | 4.17 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 78.216 M |
Share Float (%) | 60.85 M |
% Held by Institutions | 12.93 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 1.01 (-7.92%) |
+/- SMA(50) | 1.12 (-16.96%) |
+/- SMA(200) | 1.75 (-46.86%) |
5-Day Perf. | -7% |
1-Month Perf. | +1.09% |
3-Month Perf. | -41.51% |
6-Month Perf. | -54.63% |
YTD Perf. | -43.64% |
1-Year Perf. | -52.06% |
RSI(14) | 32.63 |
ATR(14) | 0.06 |
ADX(14) | 18.93 |
Beta (5Y) | 0.94 |
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
MDNA.TO has triggered the following predefined scans:
No Recent Scan Appearances |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.